Overall, they found that these NPs were associated with a reduced level of Ab, ROS, TNF-a, and IL-6, and increased activity of superoxide dismutase (SOD) and synapse numbers in AD mouse brains, leading to their potential therapeutic use in AD. This evidence concerns the gene IL6 and Alzheimer disease.